Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Autoimmunity ; 42(1): 25-32, 2009 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-18608175

RESUMEN

Rheumatoid arthritis is an autoimmune disease that affects human beings worldwide. Infections have been associated to autoimmune diseases because their ability to induce a dominant cytokine response. Joint inflammation has been related to Th1 response because they induce high expression of proinflammatory cytokines TNF-alpha, IL-1, IFN-gamma. MRL/lpr mice spontaneously develop an autoimmune disease affecting joints, kidneys, etc. We compared incidence and severity of arthritis, antibody response, cytokine production, in mice infected with bacteria or helminthes in the Murphy Roths Large (MRL)lpr mice. Infections with helminthes Heligmosomoides polygyrus, Nippostrongylus brasiliensis or bacteria Nocardia brasiliensis and Staphylococcus aureus were studied. IL-4, IFN-gamma and IgG1, IgG2a antibody productions were determined. IFN-gamma was increased in all groups, the highest production was observed after bacterial infection; IL-4 production was higher after helminthes infection. IgG1 sera levels were increased in the helminthes infected group. IgG2a sera concentration was stimulated by bacterial infection. The histopathology showed that 100% of bacterial infected mice developed arthritis and severe tissue damage such as cartilage erosion and bone destruction. Animals infected with parasites showed a decreased incidence and severity of arthritis. Severity of tissue damage in joints is correlated with increased numbers of lymphocytes and macrophages immunoreactive to proinflammatory cytokines.


Asunto(s)
Artritis Experimental/fisiopatología , Artritis Reumatoide/fisiopatología , Nippostrongylus/inmunología , Infecciones Estafilocócicas , Staphylococcus aureus/inmunología , Infecciones por Strongylida , Animales , Anticuerpos Antibacterianos/sangre , Anticuerpos Antihelmínticos/sangre , Artritis Experimental/inmunología , Artritis Reumatoide/inmunología , Citocinas/metabolismo , Modelos Animales de Enfermedad , Femenino , Humanos , Ratones , Ratones Endogámicos MRL lpr , Nippostrongylus/patogenicidad , Índice de Severidad de la Enfermedad , Infecciones Estafilocócicas/inmunología , Infecciones Estafilocócicas/microbiología , Infecciones Estafilocócicas/fisiopatología , Staphylococcus aureus/metabolismo , Staphylococcus aureus/patogenicidad , Infecciones por Strongylida/inmunología , Infecciones por Strongylida/fisiopatología , Células TH1/inmunología
2.
Crit Rev Clin Lab Sci ; 40(2): 117-49, 2003 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12755453

RESUMEN

Acute pancreatitis is a disorder that affects approximately 200,000 individuals in the U.S. annually. While most cases are mild, up to 30% of patients will have a complicated course with prolonged hospitalization and significant morbidity and mortality. Early institution of several therapeutic interventions, such as enteral nutrition, prophylactic antibiotics, endoscopic retrograde cholangiopancreatography (ERCP) and intensive care monitoring, have been shown to decrease the morbidity associated with severe acute pancreatitis. However, the ability of clinicians to predict, upon presentation, which patient will have mild or severe pancreatitis has remained poor over the years, thus leading to a delay in the institution of such treatments. Researchers have focused on markers that might improve upon clinical prediction alone. While data have shown the predictive value of tools such as Ranson's and Glasgow's criteria, C-reactive protein (CRP) and the APACHE score, their application in clinical practice has been limited by a time delay of at least 48 h in the former two and by being cumbersome in the latter. Thus, our focus is to critically appraise the evidence available for various biochemical markers in their ability to distinguish mild and severe acute pancreatitis early and more accurately than currently available tools.


Asunto(s)
Proteína C-Reactiva/análisis , Citocinas/análisis , Oligopéptidos/análisis , Pancreatitis Aguda Necrotizante/clasificación , Pancreatitis Aguda Necrotizante/diagnóstico , Índice de Severidad de la Enfermedad , Tripsinógeno/análisis , APACHE , Biomarcadores/análisis , Femenino , Indicadores de Salud , Humanos , Masculino , Pancreatitis Aguda Necrotizante/sangre , Pancreatitis Aguda Necrotizante/orina , Valor Predictivo de las Pruebas , Reproducibilidad de los Resultados , Sensibilidad y Especificidad
3.
Rev. mex. reumatol ; 16(5): 349-353, sept.-oct. 2001. ilus
Artículo en Español | LILACS | ID: lil-314430

RESUMEN

El síndrome antifosfolípido (SAF) se caracteriza por eventos trombóticos venosos y arteriales, abortos recurrentes, manifestaciones neurológicas y anticuerpos anticardiolipina. Estos últimos pueden estar asociados a enfermedades de tejido conectivo, infecciones, neoplasias y drogas. Sin embargo, la mayoría de las veces no son trombogénicos. Presentamos el caso de un paciente masculino de 52 años con un carcinoma epitelial metastásico a médula ósea con manifestaciones neurológicas, trombóticas y resológicas de SAF.


Asunto(s)
Humanos , Masculino , Persona de Mediana Edad , Neoplasias Primarias Desconocidas , Médula Ósea/patología , Síndrome Antifosfolípido/diagnóstico , Carcinoma , Anticuerpos Anticardiolipina , Metástasis de la Neoplasia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA